Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | STK33 | Q9BYT3 | 3/20 | 0.46 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | ITK | Q08881 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.43 |
| ▸ | DHODH | Q02127 | 2/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11724397 | 0.90 | PARP14 (0.55) | P2RY1HDAC2STK33PARP14ITK | |
| SCHEMBL3737843 | 0.89 | P2RY1 (0.51) | P2RY1HDAC2STK33PARP14ITK | |
| SCHEMBL3742777 | 0.84 | TOP1 (0.59) | P2RY1TDP1HDAC2STK33PARP14 | |
| SCHEMBL3738262 | 0.82 | TOP1 (0.58) | P2RY1TDP1HDAC2STK33PARP14 | |
| Pyrimidine SCHEMBL3397113 | 0.82 | ITK (0.52) | P2RY1STK33PARP14ITKKDR | |
| SCHEMBL2740082 | 0.80 | PDE4D (0.57) | MEN1TP53KMT2ACHEK1 | |
| SCHEMBL11726409 | 0.79 | P2RY1 (0.56) | P2RY1TDP1PARP14ITKMEN1 | |
| SCHEMBL3743012 | 0.79 | LMNA (0.54) | P2RY1TDP1MEN1TP53KMT2A | |
| SCHEMBL3538594 | 0.79 | P2RY1 (0.51) | P2RY1KMT2ACHEK1KDR | |
| SCHEMBL2740084 | 0.78 | MEN1 (0.56) | P2RY1TDP1STK33PARP14MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678576-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| EP-3858831-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2021-08-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678576-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | P2RY1 582/4885TDP1 3035/4885HDAC2 2218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.